Abstract
It has been reported that adult obese subjects present a reduced growth hormone secretion. As no data are available in the pubertal period, which is characterized in lean subjects by an increased spontaneous growth hormone secretion, the growth hormone circadian concentration was studied in a group of 18 obese male subjects in different pubertal stages, and compared to 26 age-matched control subjects. The data observed evidenced no statistically relevant differences regarding LH and FSH circadian secretion and morning testosterone concentration. On the contrary a statistically significant (p < 0.02) difference in growth hormone 24 h integrated concentration was evident, particularly in prepubertal subjects; the sleep-related peak was evident in 28% of obese subjects and in 85% of controls. Sm-C/IGF-I concentration was similar to the concentration observed in controls in the prepubertal stage, but did not show the expected increase in the late puberty. Auxological data, performed on a sample of 80 subjects, showed both advanced height and bone age at beginning of puberty, and a trend toward a reduction of percentile for height in parallel with the pubertal maturation, suggesting that pubertal growth spurt in obese subjects is at least less pronounced than in lean subjects. It is concluded that GH and Sm-C/IGF-I secretion is impaired during puberty in obese subjects, leading to a reduced growth rate, while in the prepubertal period factors other than GH may replace or even potentiate its action.
Similar content being viewed by others
References
Glass A.R., Burman K.D., Dahams E.W.T., Boehm T.M. Endocrine function in human obesity. Metabolism 30: 89, 1981.
Laurian L., Oberman Z., Hoerer E., Wiznitzer T., Harell A. Growth hormone response to L-Dopa in the thinned obese. Isr.J. Med. Sci. 18: 625, 1982.
Topper E., Gil-Ad I., Bauman B., Josefsberg Z., Laron Z. Plasma growth hormone response to oral Clonidine as compared to insulin hypoglycemia in obese children and adolescents. Horm. Metab. Res. 76(Suppl. 1): 127, 1984.
Vizner B., Reiner Z., Sesko M. Effect of L-Dopa on growth hormone, glucose, insulin and Cortisol response in obese subjects. Exp. Clin. Endocrinol. 81: 41, 1983.
Quabbe J.H., Helge H., Kubicki S. Nocturnal growth hormone secretion: correlation with sleeping EEG in adults and pattern in children and adolescents with nonpituitary dwarfism, overgrowth, and in obesity. Acta Endocrinol. (Kbh.) 67: 767, 1971.
Ball M.F., El-Khodary A.Z., Canary J.J. Growth hormone response in the thinned obese. J. Clin. Endocrinol. Metab. 34: 498, 1972.
Crockford P.M., Salmon P.A. Hormones and obesity: changes in insulin and growth hormone secretion following surgically induced weight loss. Can. Med. Assoc. J. 103: 147, 1970.
Kalkhoff R.K., Kim H., Cerletty J., Ferrou C. Effects of weight loss on abnormal plasma insulin and growth hormone in obese subjects. Diabetes 19: 361, 1970.
Copinschi G., De Laet M.H., Brion J.P.; Leclercq R., L’Hermite M., Robyn C., Virasoro E., Van Cauter E. Simultaneous study of Cortisol, growth hormone and prolactin nyctohemeral variations in normal and obese subjects. Influence of prolonged fasting in obesity. Clin. Endocrinol. (Oxf.) 9: 15, 1978.
Williams T., Berelowitz M., Joffe S.N., Tho.rner M.O., Rivier J., Vale W., Frohman L.A. Impaired growth hormone response to growth-hormone releasing factor in obesity. A pituitary defect reversed with weight reduction. N.Engl. J. Med. 311: 1403, 1984.
Kopelman P.G., Noonan K., Goulton R., Forrest A.J. Impaired growth hormone response to growth hormone releasing factor and insulin-hypoglycemia in obesity. Clin. Endocrinol. (Oxf.) 23: 87, 1985.
Davies R.R., Turner S.J., Cook D., Alberti K.G.M.M., Johnston D.G. The response of obese subjects to continuous infusion of human pancreatic growth-hormone releasing factor 1-44. Clin. Endocrinol. (Oxf.) 23: 521, 1985.
Pertzelan A., Keret R., Bauman B., Josefsberg Z., Ben-Zeev Z., Szoke B., Comaru-Schally A.M., Laron Z. Responsiveness of pituitary hGH to GRH "1 -44 in juveniles with obesity. Acta Endocrinol. (Kbh.) 111: 151, 1986.
Zapf J., Morell B., Walter H., Laron Z., Froesch R. Serum levels of insulin-like growth factor and its carrier protein in various metabolic disorders. Acta Endocrinol. (Kbh.) 95: 505, 1980.
Caufriez A., Golstein J., Lebrun P., Herchulez A., Furlanetto R., Copinschi J. Relations between immunoreactive somatomedin C., insulin and T3 patterns during fasting in obese subjects. Clin. Endocrinol. (Oxf.) 20: 65, 1984.
Merimee T.J., Zapf J., Froesch E.R. Insulin-like growth factors in the fed and fasted states. J. Clin. Endocrinol. Metab. 55: 99, 1982.
Nicoletti I., Bruni V., Rolla M. La diagnosi auxologica di 1° e 2° livello, per la prevenzione e la clinica, nelle alterazioni della crescita. Acta Med. Auxol. 16: 3, 1984.
Tanner J.M. Growth at adolescence, ed. 2. Blackwell Scientific Publications, Oxford, 1962.
Tanner J.M., Whitehouse R.H., Marshall W.A., Healy M.J.R., Goldstein H. Assessment of skeletal maturity and prediction of adult weight (TW2 method). Academic Press, London, 1975.
Tanner J.M., Whitehouse R. Longitudinal standards for height, weight, height velocity, weight velocity and the stage of puberty. Arch. Dis. Child. 51: 170, 1976.
Meistas M.T, Foster G.Y., Margolis S., Kowarski A.A. Integrated concentrations of growth hormone, insulin, C-peptide and prolactin in human obesity. Metabolism 31: 1224, 1982.
Minuto F., Barreca A., Ferrini S., Mazzocchi.G., Del Monte P., Giordano G. Growth hormone secretion in pubertal and adult subjects. Acta Endocrinol. (Kbh.) 99: 161, 1982.
Finkelstein J.W., Roffwarg H.P., Boyar R.M., Kream J., Hellman L. Age-related change in the twenty-four hour spontaneous secretion of growth hormone. J. Clin. Endocrinol. Metab. 35: 665, 1972.
Rosenfield R., Furlanetto R., Bock D. Relationship of somatomedin-C concentrations to pubertal changes. J. Pediatr. 103: 723, 1983.
Luna A.M., Wilson D.M., Wibbelsman C.J., Brown R.C., Nagashima R.J., Hintz R.L., Rosenfeld R.G. Somatomedins in adolescence: a cross-sectional study of the effect of puberty on plasma insulin-like growth factor I and II levels. J. Clin. Endocrinol. Metab. 57: 268, 1983.
Minuto F., Barreca A., Del Monte P., Fazzuoli L., Bevevino R., Buffa C., Fortini P., Giordano G. Somatomedins and sex hormones during puberty. IRCS Med. Sci. 13: 422, 1985.
Glukman P.D., Holdaway I.M. Prolactin and somatomedin studies in the syndrome of growth hormone independent growth. Clin. Endocrinol. (Oxf.) 5: 545, 1976.
Geffner M.E., Lippe B.A., Bersch N., Van Herle A., Kaplan S.A., Elders M.J., Golde D.W. Growth without growth hormone: evidence for a potent circulating human growth factor. Lancet 1: 343, 1986.
Dietz W.H., Hartung R. Changes in height velocity of obese preadolescents during weight reduction. Am. J. Dis. Child. 7: 705, 1985.
Author information
Authors and Affiliations
Additional information
Supported in part by research grants from Ministero della Pubblica Istruzione and Consiglio Nazionale delle Ricerche n. 84.00818.04 and n. 85.000781.04.
Rights and permissions
About this article
Cite this article
Minuto, F., Barreca, A., Del Monte, P. et al. Spontaneous growth hormone and somatomedin-C/insulin-like growth factor-l secretion in obese subjects during puberty. J Endocrinol Invest 11, 489–495 (1988). https://doi.org/10.1007/BF03350166
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03350166